[Disseminated breast carcinoma. Study of activity of immunotherapy with BCG and duration of the phase of intensive chemotherapy. Results of a randomized trial (author's transl)].

@article{Pouillart1981DisseminatedBC,
  title={[Disseminated breast carcinoma. Study of activity of immunotherapy with BCG and duration of the phase of intensive chemotherapy. Results of a randomized trial (author's transl)].},
  author={Pierre Pouillart and Thao Palangi{\'e} and Michel Jouve and Emilio Garcia-Giralt and Henri Magdelenat and Bernard Asselain},
  journal={Bulletin du cancer},
  year={1981},
  volume={68 1},
  pages={6-18}
}
144 patients with disseminated breast cancer entered into a 4 arm randomized trial. They received a chemotherapy protocol combining monthly administration of adriamycin (40 mg/m2 on day 1), vincristine (1,2 mg/m2 of day 2), cyclophosphamide (400 mg/m2 on days 3, 4, 5), 5 fluorouracil (500 mg/m2 on days 3, 4, 5). Patients in groups I and III were given 6… CONTINUE READING